tirzepatide news october 2025 Medscape | The FDA approved Zepbound in December 2024 for the treatment of moderate-to-severe obstructive sleep apnea in patients with obesity after Wow! It really shows the

The average time from transplantation to diagnosis is three to eight years, and more than 90% of tumors are BCC or SCC

[2] Some patients discover too late that slowed digestion from GLP-1s can make oral birth control less effective, while others may be prescribed GLP-1 medications by their fertility doctors

Therefore, we offer comprehensive care and guidance throughout your weight loss journey

However, bioavailability through nasal delivery is lower than injection

Alissa Chen, MD, MPH, MHS Instructor, General Internal Medicine Our approach to the treatment of obesity in older adults should be inherently different given that they have different medical needs and goals, Chen says